Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) — Financial Flexibility Index
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥12.37 Million (operating CF CN¥8.20 Million minus capex CN¥4.18 Million) represents 0% of total liabilities (CN¥658.86 Million). Check 002566 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jilin Jian Yisheng Pharmaceutical Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Jilin Jian Yisheng Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see Jilin Jian Yisheng Pharmaceutical Co Ltd cash conversion from operations.
Annual Financial Flexibility Index for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Jilin Jian Yisheng Pharmaceutical Co Ltd. Explore 002566 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥112.38 Million | CN¥98.74 Million | CN¥630.35 Million | ▲ +51.7% |
| 2024 | 0.12x | CN¥74.89 Million | CN¥58.94 Million | CN¥637.22 Million | ▼ -65.7% |
| 2023 | 0.34x | CN¥244.90 Million | CN¥209.13 Million | CN¥714.30 Million | ▲ +31.3% |
| 2022 | 0.26x | CN¥187.22 Million | CN¥145.86 Million | CN¥717.18 Million | ▼ -46.0% |
| 2021 | 0.48x | CN¥322.17 Million | CN¥215.10 Million | CN¥666.08 Million | ▲ +14.9% |
| 2020 | 0.42x | CN¥279.45 Million | CN¥203.51 Million | CN¥663.86 Million | ▼ -20.6% |
| 2019 | 0.53x | CN¥232.57 Million | CN¥210.87 Million | CN¥438.66 Million | ▲ +29.2% |
| 2018 | 0.41x | CN¥241.04 Million | CN¥167.32 Million | CN¥587.49 Million | ▼ -12.4% |
| 2017 | 0.47x | CN¥354.15 Million | CN¥270.65 Million | CN¥756.40 Million | ▲ +1004.0% |
| 2016 | 0.04x | CN¥36.88 Million | CN¥-17.52 Million | CN¥869.67 Million | ▲ +117.0% |
| 2015 | -0.25x | CN¥-222.04 Million | CN¥-324.29 Million | CN¥888.65 Million | ▲ +64.7% |
| 2014 | -0.71x | CN¥-523.57 Million | CN¥-592.06 Million | CN¥739.24 Million | ▼ -30.4% |
| 2013 | -0.54x | CN¥-116.10 Million | CN¥-188.45 Million | CN¥213.79 Million | ▼ -123.7% |
| 2012 | 2.29x | CN¥166.62 Million | CN¥79.08 Million | CN¥72.81 Million | ▲ +318.1% |
| 2011 | -1.05x | CN¥-67.69 Million | CN¥-112.12 Million | CN¥64.52 Million | ▼ -263.9% |
| 2010 | 0.64x | CN¥99.62 Million | CN¥50.73 Million | CN¥155.66 Million | ▼ -44.0% |
| 2009 | 1.14x | CN¥167.66 Million | CN¥125.25 Million | CN¥146.67 Million | ▲ +348.5% |
| 2008 | 0.25x | CN¥32.48 Million | CN¥20.50 Million | CN¥127.43 Million | ▼ -63.1% |
| 2007 | 0.69x | CN¥94.08 Million | CN¥82.66 Million | CN¥136.08 Million | ▲ +58.5% |
| 2006 | 0.44x | CN¥43.33 Million | CN¥25.58 Million | CN¥99.35 Million | — |